Moderna and Oxford Launch Phase 1/2 Trial of mRNA Cancer Vaccine for Lynch Syndrome
OXFORD, UK AND CAMBRIDGE, Massachusetts – June 8, 2026 Moderna and the University of Oxford have received authorization from...
Alzheimer’s Disease artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Eli Lilly FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
OXFORD, UK AND CAMBRIDGE, Massachusetts – June 8, 2026 Moderna and the University of Oxford have received authorization from...
NEW BRUNSWICK, New Jersey, USA – June 8, 2026 Johnson & Johnson has announced a definitive agreement to acquire...
MILFORD, Massachusetts, USA – June 3, 2026 Waters Corporation has announced U.S. Food and Drug Administration (FDA) 510(k) clearance...
WALTHAM, Mass., May 13, 2026 Revvity, Inc. has received U.S. FDA clearance for its Total Testosterone automated chemiluminescence immunoassay...
BETHLEHEM, PA, April 7, 2026 Saladax Biomedical, Inc. has announced a strategic distribution agreement with Thermo Fisher Scientific to...
BOSTON, January 22, 2026 — Delve Bio announced new clinical evidence demonstrating that earlier use of metagenomic next-generation sequencing...
LA JOLLA, Calif., Dec. 17, 2025 — Singlera Genomics announced a strategic research collaboration with the University of Pittsburgh...
FRIENDSWOOD, Texas — December 12, 2025 — Castle Biosciences, Inc., a diagnostics company advancing precision medicine in gastroenterology, announced...
Dateline — CARLSBAD, Calif., November 11, 2025:Exagen Inc. (Nasdaq: XGN), a leader in autoimmune diagnostics, has announced its participation...
Grove City, Ohio – October 30, 2025 — Tosoh Bioscience, Inc., a global leader in clinical diagnostics and laboratory...
